GB202115200D0 - Retentive formulation - Google Patents

Retentive formulation

Info

Publication number
GB202115200D0
GB202115200D0 GBGB2115200.4A GB202115200A GB202115200D0 GB 202115200 D0 GB202115200 D0 GB 202115200D0 GB 202115200 A GB202115200 A GB 202115200A GB 202115200 D0 GB202115200 D0 GB 202115200D0
Authority
GB
United Kingdom
Prior art keywords
retentive formulation
retentive
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2115200.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drug Delivery International Ltd
Original Assignee
Drug Delivery International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery International Ltd filed Critical Drug Delivery International Ltd
Priority to GBGB2115200.4A priority Critical patent/GB202115200D0/en
Publication of GB202115200D0 publication Critical patent/GB202115200D0/en
Ceased legal-status Critical Current

Links

GBGB2115200.4A 2021-10-22 2021-10-22 Retentive formulation Ceased GB202115200D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2115200.4A GB202115200D0 (en) 2021-10-22 2021-10-22 Retentive formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2115200.4A GB202115200D0 (en) 2021-10-22 2021-10-22 Retentive formulation

Publications (1)

Publication Number Publication Date
GB202115200D0 true GB202115200D0 (en) 2021-12-08

Family

ID=78805957

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2115200.4A Ceased GB202115200D0 (en) 2021-10-22 2021-10-22 Retentive formulation

Country Status (1)

Country Link
GB (1) GB202115200D0 (en)

Similar Documents

Publication Publication Date Title
GB202008303D0 (en) Therapeutic compositions
IL285674A (en) Pharmaceutical formulations
IL290894A (en) Pharmaceutical formulation
GB202007546D0 (en) Formulation
GB202010230D0 (en) Pharmaceutical formulation
IL297081A (en) Pharmaceutical formulation
GB202018889D0 (en) Formulations
GB202115200D0 (en) Retentive formulation
GB202009684D0 (en) Formulations
GB201906473D0 (en) Pharmaceutical formulation
GB201905878D0 (en) Retentive formulation
IL305977A (en) Formulation comprising ceralasertib
IL307849A (en) Sotorasib formulation
IL308046A (en) Alpelisib formulation
GB202108165D0 (en) Formulation
GB202107439D0 (en) Formulation
GB202107203D0 (en) Formulation
GB202103970D0 (en) Formulation
GB202102636D0 (en) Formulation
GB202102408D0 (en) Formulation
GB202016274D0 (en) Formulation
ZA202212663B (en) Pharmaceutical formulations
GB202010573D0 (en) Formulation
IL308250A (en) Pharmaceutical formulations
GB202006008D0 (en) Aerosolisable formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)